Tiziana Life Sciences – Clinical pipeline update, resolutions seeking shareholder authority to issue new shares for cash & approval of proposed option grant April 21, 2020 – Posted in: Tiziana Life Sciences (TILS)

London, New York 21 April 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), the U.S. and U.K. biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that it has convened a general meeting (the “GM”) to consider proposals to take increased authorities to allot shares; consider the replacement of share option awards and to adopt…

Tiziana Life Sciences #TILS – CEO Gabriele Cerrone Adds To Shareholding February 4, 2020 – Posted in: Tiziana Life Sciences (TILS)

New York/London, 4 February 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on the 3 February 2020 it was informed that on that date, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought 5,000 ADSs (each representing 5 Ordinary Shares) at a price of $2.37 per ADS, as set out…

Tiziana Life Sciences #TILS – Exec Chairman Gabriele Cerrone purchases more shares January 14, 2020 – Posted in: Tiziana Life Sciences (TILS)

New York/London, 14 January 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on the 13 January 2020 it was informed that on that date, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought 28,500 Ordinary Shares at a price of 43 pence per Ordinary Share, as set out below. The…

Tiziana Life Sciences #TILS – Director Dealing, Exec Chairman Gabriele Cerrone purchases 12,500 ADSs January 2, 2020 – Posted in: Tiziana Life Sciences (TILS)

New York/London, 2 January 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on 31 December 2019, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought 12,500 ADSs each representing 5 ordinary shares of nominal value 3p each in the capital of the Company at a price of US$2.79 per ADS,…

Tiziana Life Sciences – Clinical pipeline update, resolutions seeking shareholder authority to issue new shares for cash & approval of proposed option grant April 21, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences #TILS – CEO Gabriele Cerrone Adds To Shareholding February 4, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences #TILS – Exec Chairman Gabriele Cerrone purchases more shares January 14, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences #TILS – Director Dealing, Exec Chairman Gabriele Cerrone purchases 12,500 ADSs January 2, 2020 – Posted in: Tiziana Life Sciences (TILS)

Address

Contact

Social

LEGAL